AzurRx BioPharma, Inc.
AZRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,153 | -$998 | -$1,260 | $31,577 |
| Dep. & Amort. | $0 | $0 | $0 | $167 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | -$607 |
| Change in WC | $0 | -$314 | $0 | $12,323 |
| Other Non-Cash | $297 | $1,258 | $441 | -$36,090 |
| Operating Cash Flow | -$856 | -$55 | -$819 | $7,368 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $74 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $336 | $0 | $0 | $8,998 |
| Investing Cash Flow | $336 | $0 | $0 | $9,072 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,025 | $0 | $0 | -$9,680 |
| Stock Repurch. | $0 | $0 | $0 | -$17,558 |
| Dividends Paid | $0 | -$163 | -$81 | $8,155 |
| Other Fin. Act. | $3,116 | $163 | $781 | -$8,889 |
| Financing Cash Flow | $3,025 | $0 | $700 | -$16,804 |
| Forex Effect | $0 | $0 | $0 | $109 |
| Net Chg. in Cash | $2,506 | -$55 | -$119 | -$7,889 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11 | $66 | $185 | $8,074 |
| End Cash | $2,517 | $11 | $66 | $185 |
| Free Cash Flow | -$856 | -$55 | -$819 | $7,442 |